BA
Bennicas & Associates Portfolio holdings
AUM
$173M
This Quarter Return
+5.35%
1 Year Return
+1.55%
3 Year Return
+40.3%
5 Year Return
+86.09%
10 Year Return
–
AUM
$129M
AUM Growth
+$129M
(+7.7%)
Cap. Flow
+$3.58M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
40.83%
Holding
83
New
–
Increased
12
Reduced
26
Closed
–
Top Buys
| 1 |
AbbVie
ABBV
|
$3.02M |
| 2 |
Procter & Gamble
PG
|
$550K |
| 3 |
Sprott Physical Gold and Silver Trust
CEF
|
$83.5K |
| 4 |
TotalEnergies
TTE
|
$78K |
| 5 |
AT&T
T
|
$60.6K |
Top Sells
| 1 |
Oracle
ORCL
|
$110K |
| 2 |
Copart
CPRT
|
$64.3K |
| 3 |
Clorox
CLX
|
$15.2K |
| 4 |
DNP Select Income Fund
DNP
|
$14.5K |
| 5 |
Healthpeak Properties
DOC
|
$14.3K |
Sector Composition
| 1 | Consumer Staples | 24.52% |
| 2 | Healthcare | 13.63% |
| 3 | Materials | 11.59% |
| 4 | Technology | 8.8% |
| 5 | Real Estate | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pan American Silver
PAAS
$12.3B
| $1.75M | 1.35% |
111,269
+3,500
| +3% | +$54.9K |
|
27
Southern Company
SO
$101B
| $1.73M | 1.34% |
28,050
| – | – |
|
28
Chevron
CVX
$318B
| $1.65M | 1.27% |
13,882
| – | – |
|
29
Eli Lilly
LLY
$661B
| $1.61M | 1.25% |
14,402
+57
| +0.4% | +$6.38K |
|
30
Lockheed Martin
LMT
$105B
| $1.52M | 1.18% |
3,890
| – | – |
|
31
Unilever
UL
$158B
| $1.51M | 1.17% |
25,065
-100
| -0.4% | -$6.01K |
|
32
Kimberly-Clark
KMB
$42.5B
| $1.49M | 1.16% |
10,500
| – | – |
|
33
Bristol-Myers Squibb
BMY
$96.7B
| $1.47M | 1.14% |
28,975
| – | – |
|
34
Abbott
ABT
$230B
| $1.47M | 1.14% |
17,543
| – | – |
|
|
GRX
35
Gabelli Healthcare & Wellness Trust
GRX
$147M
| $1.43M | 1.11% |
137,500
| – | – |
|
36
Kellanova
K
$27.5B
| $1.4M | 1.09% |
21,825
-150
| -0.7% | -$9.6K |
|
37
Gilead Sciences
GILD
$140B
| $1.36M | 1.05% |
21,400
-150
| -0.7% | -$9.51K |
|
38
RTX Corp
RTX
$212B
| $1.29M | 1% |
9,439
| – | – |
|
39
Verizon
VZ
$184B
| $1.29M | 1% |
21,292
-200
| -0.9% | -$12.1K |
|
|
40
AT&T
T
$208B
| $1.28M | 0.99% |
33,763
+1,600
| +5% | +$60.6K |
|
41
Sanofi
SNY
$122B
| $1.24M | 0.96% |
26,709
| – | – |
|
|
42
TotalEnergies
TTE
$135B
| $1.17M | 0.9% |
22,450
+1,500
| +7% | +$78K |
|
43
Johnson & Johnson
JNJ
$429B
| $1.09M | 0.85% |
8,450
| – | – |
|
44
Weyerhaeuser
WY
$17.9B
| $1.08M | 0.84% |
39,066
| – | – |
|
|
45
DNP Select Income Fund
DNP
$3.67B
| $950K | 0.74% |
73,851
-1,125
| -2% | -$14.5K |
|
46
Agnico Eagle Mines
AEM
$74.7B
| $906K | 0.7% |
16,900
-100
| -0.6% | -$5.36K |
|
47
Apple
AAPL
$3.54T
| $851K | 0.66% |
3,798
-25
| -0.7% | -$5.6K |
|
|
48
Healthpeak Properties
DOC
$12.3B
| $822K | 0.64% |
23,074
-400
| -2% | -$14.3K |
|
49
Bunge Global
BG
$16.3B
| $818K | 0.63% |
14,450
| – | – |
|
50
Pfizer
PFE
$141B
| $793K | 0.61% |
22,075
| – | – |
|